Real-world effectiveness of adjuvanted RSVPreF3 vaccination in the prevention of RSV-related hospitalization among US adults aged ≥60 years.
Saved in:
| Title: | Real-world effectiveness of adjuvanted RSVPreF3 vaccination in the prevention of RSV-related hospitalization among US adults aged ≥60 years. |
|---|---|
| Authors: | Singer D; GSK, Philadelphia, PA, US., Steffens A; Optum, Eden Prairie, MN, US., La EM; GSK, Philadelphia, PA, US., Buikema AR; Optum, Eden Prairie, MN, US., Horn EK; GSK, Philadelphia, PA, US. Electronic address: emily.k.horn@gsk.com., Theiss-Nyland K; GSK, London, UK., Fonseca MJ; GSK, Lisbon, Portugal., Gerber SI; GSK, Philadelphia, PA, US., Kawai A; RTI Health Solutions, Durham, NC, US., Johnson MG; Optum, Eden Prairie, MN, US., Song R; Optum, Eden Prairie, MN, US., Hague S; Optum, Eden Prairie, MN, US., Layton JB; RTI Health Solutions, Durham, NC, US. |
| Source: | Chest [Chest] 2026 Jul 16. Date of Electronic Publication: 2026 Jul 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1931-3543 (Electronic) Linking ISSN: 00123692 NLM ISO Abbreviation: Chest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1931-3543 |
|---|---|
| DOI: | 10.1016/j.chest.2026.07.5002 |
